Mesa Laboratories Inc (MLAB)

Cash conversion cycle

Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Days of inventory on hand (DOH) days 105.14 114.73 124.29 134.89 158.23 142.14 151.38 148.08 141.93 112.08 120.14 119.36 133.80 84.80 88.44 86.27 87.99 81.38 89.55
Days of sales outstanding (DSO) days 63.57 59.33 64.30 58.03 65.94 61.77 62.07 59.25 70.89 69.59 68.50 76.41 81.63 83.29 57.82 54.07 64.82 57.23 53.07 53.93
Number of days of payables days 15.28 23.10 22.14 24.94 20.03 20.79 23.79 26.22 26.45 30.93 33.78 38.31 44.15 31.23 29.51 34.52 27.58 12.73 19.52
Cash conversion cycle days 63.57 149.19 155.93 160.18 175.89 199.97 183.42 186.84 192.75 185.07 149.65 162.76 162.68 172.93 111.38 112.99 116.57 117.63 121.72 123.96

March 31, 2025 calculation

Cash conversion cycle = DOH + DSO – Number of days of payables
= — + 63.57 – —
= 63.57

The cash conversion cycle of Mesa Laboratories Inc has shown fluctuation over the years based on the provided data. The cash conversion cycle is a measure of the time it takes for a company to convert its investments in inventory and other resources into cash flows from sales.

From June 30, 2020, to December 31, 2021, the trend was generally decreasing, indicating an improvement in the efficiency of Mesa Laboratories' working capital management. However, there was a significant increase in the cash conversion cycle from December 31, 2021, to March 31, 2022, followed by fluctuations until March 31, 2025.

The company's cash conversion cycle peaked at 199.97 days on December 31, 2023, and decreased significantly to 63.57 days by March 31, 2025, indicating a more efficient management of the company's working capital during that period.

Overall, Mesa Laboratories Inc should aim to maintain a lower cash conversion cycle to improve liquidity, optimize working capital management, and enhance overall financial performance. Fluctuations in the cash conversion cycle should be monitored to identify any potential inefficiencies in the company's operations that may require attention.